Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2002 Aug;87(2):135–138. doi: 10.1136/adc.87.2.135

Urogenital abnormalities in male children with cystic fibrosis

H Blau 1, E Freud 1, H Mussaffi 1, M Werner 1, O Konen 1, V Rathaus 1
PMCID: PMC1719175  PMID: 12138064

Abstract

Background: Congenital bilateral absence of the vas deferens (CBAVD) is presumed to occur prenatally and is present in over 99% of adult males with cystic fibrosis (CF).

Aims: To describe ultrasonic features in male children with CF. We aimed to describe urogenital anomalies, comparing pancreatic sufficient and insufficient CF patients.

Methods: Pelvic and scrotal ultrasonography were performed in 12 boys with CF aged 2–12 years and 16 age matched healthy controls.

Results: Nine patients had pancreatic insufficiency (PI): seven had two severe mutations and two had unknown mutations. Three boys were pancreatic sufficient (PS), two with splicing mutations (5T and 3849+10kb C–T respectively) and borderline sweat tests. Seminal vesicles were visualised in 5/12 patients and 8/16 controls, compared to non-visualisation reported in all adults with CBAVD. Testicular microlithiasis was found in 4/18 PI, 0/6 PS, and 0/32 control testes, compared to 0.6–1.4% in healthy males and 15% in CF adults; 7/18 PI, 4/6 PS, and 0/32 control testes were smaller than predicted for age. The epididymal head was non-homogeneous with cysts, hypo-, or hyper-echogenicity in 5/18 PI, 1/6 PS, and 0/32 control testes.

Conclusions: Genital abnormalities may occur early in CF, but are less common than described in adults. They are found more often in pancreatic insufficient than in pancreatic sufficient CF patients. However, a positive finding, if present, may aid in the diagnosis of the latter. A larger longitudinal study is recommended to better define the onset and progression of urogenital abnormalities.

Full Text

The Full Text of this article is available as a PDF (107.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Augarten A., Kerem B. S., Yahav Y., Noiman S., Rivlin Y., Tal A., Blau H., Ben-Tur L., Szeinberg A., Kerem E. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation. Lancet. 1993 Jul 3;342(8862):25–26. doi: 10.1016/0140-6736(93)91885-p. [DOI] [PubMed] [Google Scholar]
  2. Chillón M., Casals T., Mercier B., Bassas L., Lissens W., Silber S., Romey M. C., Ruiz-Romero J., Verlingue C., Claustres M. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. 1995 Jun 1;332(22):1475–1480. doi: 10.1056/NEJM199506013322204. [DOI] [PubMed] [Google Scholar]
  3. Doull I. J. Recent advances in cystic fibrosis. Arch Dis Child. 2001 Jul;85(1):62–66. doi: 10.1136/adc.85.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dreyfus D. H., Bethel R., Gelfand E. W. Cystic fibrosis 3849+10kb C > T mutation associated with severe pulmonary disease and male fertility. Am J Respir Crit Care Med. 1996 Feb;153(2):858–860. doi: 10.1164/ajrccm.153.2.8564145. [DOI] [PubMed] [Google Scholar]
  5. Gaillard D. A., Carré-Pigeon F., Lallemand A. Normal vas deferens in fetuses with cystic fibrosis. J Urol. 1997 Oct;158(4):1549–1552. [PubMed] [Google Scholar]
  6. Holsclaw D. S., Perlmutter A. D., Jockin H., Shwachman H. Genital abnormalities in male patients with cystic fibrosis. J Urol. 1971 Oct;106(4):568–574. doi: 10.1016/s0022-5347(17)61343-0. [DOI] [PubMed] [Google Scholar]
  7. Höbarth K., Susani M., Szabo N., Kratzik C. Incidence of testicular microlithiasis. Urology. 1992 Nov;40(5):464–467. doi: 10.1016/0090-4295(92)90467-b. [DOI] [PubMed] [Google Scholar]
  8. Ingram S., Hollman A. S., Azmy A. F. Ultrasound evaluation of the paediatric prostate. Br J Urol. 1994 Nov;74(5):601–603. doi: 10.1111/j.1464-410x.1994.tb09191.x. [DOI] [PubMed] [Google Scholar]
  9. Jarvi K., McCallum S., Zielenski J., Durie P., Tullis E., Wilchanski M., Margolis M., Asch M., Ginzburg B., Martin S. Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations. Fertil Steril. 1998 Oct;70(4):724–728. doi: 10.1016/s0015-0282(98)00247-7. [DOI] [PubMed] [Google Scholar]
  10. Kerem E., Kalman Y. M., Yahav Y., Shoshani T., Abeliovich D., Szeinberg A., Rivlin J., Blau H., Tal A., Ben-Tur L. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel. Hum Genet. 1995 Aug;96(2):193–197. doi: 10.1007/BF00207378. [DOI] [PubMed] [Google Scholar]
  11. Landing B. H., Wells T. R., Wang C. I. Abnormality of the epididymis and vas deferens in cystic fibrosis. Arch Pathol. 1969 Dec;88(6):569–580. [PubMed] [Google Scholar]
  12. McCallum T. J., Milunsky J. M., Cunningham D. L., Harris D. H., Maher T. A., Oates R. D. Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes. Chest. 2000 Oct;118(4):1059–1062. doi: 10.1378/chest.118.4.1059. [DOI] [PubMed] [Google Scholar]
  13. Mickle J. E., Cutting G. R. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am. 2000 May;84(3):597–607. doi: 10.1016/s0025-7125(05)70243-1. [DOI] [PubMed] [Google Scholar]
  14. Oppenheimer E. H., Esterly J. R. Observations on cystic fibrosis of the pancreas. V. Developmental changes in the male genital system. J Pediatr. 1969 Nov;75(5):806–811. doi: 10.1016/s0022-3476(69)80303-3. [DOI] [PubMed] [Google Scholar]
  15. Owers K. L., Pyman J., Gargan M. F., Witherow P. J., Portinaro N. M. Bilateral hip surgery in severe cerebral palsy a preliminary review. J Bone Joint Surg Br. 2001 Nov;83(8):1161–1167. doi: 10.1302/0301-620x.83b8.11266. [DOI] [PubMed] [Google Scholar]
  16. Rodgers H. C., Knox A. J. Pharmacological treatment of the biochemical defect in cystic fibrosis airways. Eur Respir J. 2001 Jun;17(6):1314–1321. doi: 10.1183/09031936.01.00086201. [DOI] [PubMed] [Google Scholar]
  17. Schlegel P. N., Shin D., Goldstein M. Urogenital anomalies in men with congenital absence of the vas deferens. J Urol. 1996 May;155(5):1644–1648. [PubMed] [Google Scholar]
  18. Shin D., Gilbert F., Goldstein M., Schlegel P. N. Congenital absence of the vas deferens: incomplete penetrance of cystic fibrosis gene mutations. J Urol. 1997 Nov;158(5):1794–1799. doi: 10.1016/s0022-5347(01)64131-4. [DOI] [PubMed] [Google Scholar]
  19. Stern R. C., Boat T. F., Doershuk C. F. Obstructive azoospermia as a diagnostic criterion for the cystic fibrosis syndrome. Lancet. 1982 Jun 19;1(8286):1401–1404. doi: 10.1016/s0140-6736(82)92512-0. [DOI] [PubMed] [Google Scholar]
  20. Taussig L. M., Lobeck C. C., di Sant'Agnese P. A., Ackerman D. R., Kattwinkel J. Fertility in males with cystic fibrosis. N Engl J Med. 1972 Sep 21;287(12):586–589. doi: 10.1056/NEJM197209212871204. [DOI] [PubMed] [Google Scholar]
  21. Tizzano E. F., Chitayat D., Buchwald M. Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. Hum Mol Genet. 1993 Mar;2(3):219–224. doi: 10.1093/hmg/2.3.219. [DOI] [PubMed] [Google Scholar]
  22. Tizzano E. F., Silver M. M., Chitayat D., Benichou J. C., Buchwald M. Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis. Am J Pathol. 1994 May;144(5):906–914. [PMC free article] [PubMed] [Google Scholar]
  23. Wellesley D., Schwarz M., Wellesey D. Cystic fibrosis, Young's syndrome, and normal sweat chloride. Lancet. 1998 Jul 4;352(9121):38–38. doi: 10.1016/s0140-6736(05)79519-2. [DOI] [PubMed] [Google Scholar]
  24. Wilschanski M., Corey M., Durie P., Tullis E., Bain J., Asch M., Ginzburg B., Jarvi K., Buckspan M., Hartwick W. Diversity of reproductive tract abnormalities in men with cystic fibrosis. JAMA. 1996 Aug 28;276(8):607–608. [PubMed] [Google Scholar]
  25. Wilschanski M., Famini H., Strauss-Liviatan N., Rivlin J., Blau H., Bibi H., Bentur L., Yahav Y., Springer H., Kramer M. R. Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J. 2001 Jun;17(6):1208–1215. doi: 10.1183/09031936.01.00092501. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES